Literature DB >> 5138344

[Pharmacokinetics of alpha-methyldopa in kidney failure].

K Schrader, H Brass, D Renner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5138344     DOI： 10.1007/BF01495520

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  9 in total

1.  THE METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS.

Authors:  R P BUHS; J L BECK; O C SPETH; J L SMITH; N R TRENNER; P J CANNON; J H LARAGH
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  A METABOLIC STUDY OF ALPHA-METHYL-BETA-(3,4-DIHYDROXYPHENYL)-DL-ALANINE IN MAN.

Authors:  T L SOURKES; G F MURPHY; B CHAVEZ-LARA
Journal:  J Med Pharm Chem       Date:  1962-01

3.  STUDIES ON THE METABOLISM AND MECHANISM OF ACTION OF METHYLDOPA.

Authors:  A SJOERDSMA; A VENDSALU; K ENGELMAN
Journal:  Circulation       Date:  1963-10       Impact factor: 29.690

4.  [CATECHOLAMINE DETERMINATION IN THE HUMAN URINE DURING AND AFTER METHYLDOPA ADMINISTRATION].

Authors:  K SCHLOSSMANN; K D BOCK; G KRONEBERG
Journal:  Klin Wochenschr       Date:  1964-05-01

5.  Methyldopa in hypertension. Clinical and pharmacological studies.

Authors:  C T DOLLERY; M HARINGTON
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

6.  [On the diagnostic value of semi-quantitative kidney function tests. I. Correlation of plasma concentration of "genuine" endogenous creatinine and inulin clearance].

Authors:  D P MERTZ; H SARRE; Z CREMER
Journal:  Klin Wochenschr       Date:  1962-07-01

7.  [On the diagnostic value of semiquantitative kidney function tests. III. Correlations between the plasma concentrations of rest nitrogen and "true" endogenous creatinine and inulin clearance].

Authors:  D P MERTZ; H SARRE; Z CREMER
Journal:  Klin Wochenschr       Date:  1962-09-01

8.  [Experimental animal studies with alpha-methyldopa-14C, with special attention to the optical isomers. II. Organ distribution].

Authors:  B Duhm; W Maul; H Medenwald; K Patzschke; L A Wegner
Journal:  Z Naturforsch B       Date:  1967-01       Impact factor: 1.047

9.  The nature of the alpha-methyldopa red-cell antibody.

Authors:  A F LoBuglio; J H Jandl
Journal:  N Engl J Med       Date:  1967-03-23       Impact factor: 91.245
  9 in total
  3 in total

1.  Pharmacokinetics of methyldopa in healthy man.

Authors:  O Stenbaek; E Myhre; H E Rugstad; E Arnold; T Hansen
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

2.  Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.

Authors:  J A Saavedra; J L Reid; W Jordan; M D Rawlins; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of methyldopa.

Authors:  E Myhre; H E Rugstad; T Hansen
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.